In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.
about
Human immunodeficiency virus type-1 episomal cDNA in semen.A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles.How to Define the Latent Reservoir: Tools of the TradeRedefining the viral reservoirs that prevent HIV-1 eradicationA historical sketch of the discovery and development of HIV-1 integrase inhibitorsEpisomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failureDeep molecular characterization of HIV-1 dynamics under suppressive HAARTIntensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infectedIn-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate.HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.Host hindrance to HIV-1 replication in monocytes and macrophages.Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy.Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adultsHIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapyImmunization delivered by lentiviral vectors for cancer and infectious diseases.Comparative analysis of measures of viral reservoirs in HIV-1 eradication studiesThe role of unintegrated DNA in HIV infectionIntegrated and Total HIV-1 DNA Predict Ex Vivo Viral OutgrowthIndependent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue.Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trialsShort communication: HIV type 1 accumulates in influenza-specific T cells in subjects receiving seasonal vaccination in the context of effective antiretroviral therapy.Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipientsPeripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.Cell-associated HIV RNA: a dynamic biomarker of viral persistence.HIV rebounds from latently infected cells, rather than from continuing low-level replicationPersistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.HIV-1 transcription and latency: an update.Impact of the DNA extraction method on 2-LTR DNA circle recovery from HIV-1 infected cellsLack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trialAn HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.Modeling HIV persistence, the latent reservoir, and viral blips.Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques.Integration-deficient lentiviral vectors: a slow coming of age.Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification.HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.Attacking the HIV reservoir from the immune and viral perspective.
P2860
Q24813631-0EA30293-A2AF-465B-8431-60606EE18DA0Q24815183-F156965C-E58E-4F8A-842B-A70BEEDFB31CQ26766705-9F1FCBB5-BB3D-4503-A878-9CFFBB5B5AF0Q26827255-85C6EC57-C048-4EB3-AD52-E2120B5B64EDQ28274166-FFE9224C-8E34-434D-A16D-E10B4242DBA2Q28477257-38A11F3C-9D24-4736-882C-A322DC066987Q28477677-F6A1DEE2-0CF2-4818-9D54-AAA669718886Q28741704-9DB38C95-45BD-40B3-B077-4D9B458A93AFQ30479242-FD3136A8-0816-4569-91E3-1097F3862899Q33513977-8477BA41-3937-4A5A-A39C-14C29586E44AQ33846376-4D6F3140-5943-48E2-9750-162B517241FEQ33936651-73C89DA6-415B-4A20-97CF-D1427444AC5CQ34057868-E85946C2-CA6D-4CD8-805E-FECED69C07DAQ34097573-B0B69F4B-BA61-4532-96BD-3D9ECA658A26Q34354110-60C14B94-CBD4-4F96-9236-A635BF7E5E6FQ34539879-43BB91E6-E723-4AAD-B564-88F68CF80276Q34607763-14D2B029-D21A-4CFD-BE3F-E598D2D59EC7Q35143730-787167D1-9872-4DB1-B750-2496B88182ACQ35944804-A077E8BE-2ED8-4025-B748-679C4A6FFF8AQ35996364-D9A621B5-44AC-4450-8B5A-077C28F02909Q36102538-BA1AA6BE-8CF0-46A6-A528-65ED00FA1FDDQ36311695-B67AC19F-4075-44F0-AD8C-44381E5E17D4Q36408455-75678556-7182-4BC1-9735-B87B9FEB80B6Q36419518-97BEF1FE-EBF9-47A7-A774-70F38A6B0DE6Q36446222-1F77903E-4CF1-4774-83BE-537FBB48586AQ36736667-64E0E255-57FF-4A3C-97E3-F37E07148789Q36798408-84875ADD-391E-4243-AEE0-E9BA2F8875F5Q36954950-5C4EAA01-744A-48DC-A989-4A56C64CC1B6Q36957851-E70A578B-6932-4ABE-8CF9-CD35FBFAB39FQ36976156-6A1FF871-C0BB-4964-A7E0-85FDEDB2D50DQ37141282-6E56DEB3-6824-4EB6-83D5-8A7CE697DFBDQ37145779-FB61441D-2814-441E-99BB-053AECDEE1BDQ37213057-5AE95076-751D-4C65-AA5F-D72A5C2C709DQ37336473-9FDFE1B5-4740-41AA-A9D4-C7FCFD90D0BAQ37365718-4A6B0EE0-EE9E-4136-9BDF-4F95E300EBFEQ37460585-2B2F6CA9-B28B-418C-BDE1-648E13B8BF8CQ37506025-34AFBE7E-3070-4EC1-8EA3-B8EA0C69FF8AQ37621893-1DD56CA4-9F9E-40EC-9E28-C2F1DDB82297Q37643783-EF0A195F-6DE0-4093-8B3F-6FC43B7A5BC0Q38067646-2C89532B-1656-485F-9017-FA1BE16B3161
P2860
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.
@ast
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.
@en
type
label
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.
@ast
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.
@en
prefLabel
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.
@ast
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.
@en
P2093
P2860
P1433
P1476
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.
@en
P2093
Daniel R Kuritzkes
Karine Triques
Mario Stevenson
Mark Sharkey
P2860
P304
P356
10.1128/JVI.79.8.5203-5210.2005
P577
2005-04-01T00:00:00Z